Re; Singh S, Patil S, Tamhankar AS, Ahluwalia P, Gautam G. Low-risk prostate cancer in India: Is active surveillance a valid treatment option? Indian J Urol 2020;36:184-90

Detalles Bibliográficos
Autores principales: Sharma, Aditya P., Chaudhary, Kapil, Devana, Sudheer K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Letters to Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759185/
https://www.ncbi.nlm.nih.gov/pubmed/33376277
http://dx.doi.org/10.4103/iju.IJU_386_20
_version_ 1783627078138068992
author Sharma, Aditya P.
Chaudhary, Kapil
Devana, Sudheer K.
author_facet Sharma, Aditya P.
Chaudhary, Kapil
Devana, Sudheer K.
author_sort Sharma, Aditya P.
collection PubMed
description
format Online
Article
Text
id pubmed-7759185
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-77591852020-12-28 Re; Singh S, Patil S, Tamhankar AS, Ahluwalia P, Gautam G. Low-risk prostate cancer in India: Is active surveillance a valid treatment option? Indian J Urol 2020;36:184-90 Sharma, Aditya P. Chaudhary, Kapil Devana, Sudheer K. Indian J Urol Letters to Editor Wolters Kluwer - Medknow 2020 2020-10-01 /pmc/articles/PMC7759185/ /pubmed/33376277 http://dx.doi.org/10.4103/iju.IJU_386_20 Text en Copyright: © 2020 Indian Journal of Urology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Letters to Editor
Sharma, Aditya P.
Chaudhary, Kapil
Devana, Sudheer K.
Re; Singh S, Patil S, Tamhankar AS, Ahluwalia P, Gautam G. Low-risk prostate cancer in India: Is active surveillance a valid treatment option? Indian J Urol 2020;36:184-90
title Re; Singh S, Patil S, Tamhankar AS, Ahluwalia P, Gautam G. Low-risk prostate cancer in India: Is active surveillance a valid treatment option? Indian J Urol 2020;36:184-90
title_full Re; Singh S, Patil S, Tamhankar AS, Ahluwalia P, Gautam G. Low-risk prostate cancer in India: Is active surveillance a valid treatment option? Indian J Urol 2020;36:184-90
title_fullStr Re; Singh S, Patil S, Tamhankar AS, Ahluwalia P, Gautam G. Low-risk prostate cancer in India: Is active surveillance a valid treatment option? Indian J Urol 2020;36:184-90
title_full_unstemmed Re; Singh S, Patil S, Tamhankar AS, Ahluwalia P, Gautam G. Low-risk prostate cancer in India: Is active surveillance a valid treatment option? Indian J Urol 2020;36:184-90
title_short Re; Singh S, Patil S, Tamhankar AS, Ahluwalia P, Gautam G. Low-risk prostate cancer in India: Is active surveillance a valid treatment option? Indian J Urol 2020;36:184-90
title_sort re; singh s, patil s, tamhankar as, ahluwalia p, gautam g. low-risk prostate cancer in india: is active surveillance a valid treatment option? indian j urol 2020;36:184-90
topic Letters to Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7759185/
https://www.ncbi.nlm.nih.gov/pubmed/33376277
http://dx.doi.org/10.4103/iju.IJU_386_20
work_keys_str_mv AT sharmaadityap resinghspatilstamhankarasahluwaliapgautamglowriskprostatecancerinindiaisactivesurveillanceavalidtreatmentoptionindianjurol20203618490
AT chaudharykapil resinghspatilstamhankarasahluwaliapgautamglowriskprostatecancerinindiaisactivesurveillanceavalidtreatmentoptionindianjurol20203618490
AT devanasudheerk resinghspatilstamhankarasahluwaliapgautamglowriskprostatecancerinindiaisactivesurveillanceavalidtreatmentoptionindianjurol20203618490

Ejemplares similares